Golden LEAF Biomanufacturing Training and Education Center

The Golden LEAF Biomanufacturing Training and Education Center (BTEC) is a multidisciplinary instructional center at North Carolina State University that provides education and training to develop skilled professionals for the biomanufacturing industry. Biomanufacturing refers to the use of living organisms or other biological material to produce commercially viable products. Examples include therapeutic proteins, monoclonal antibodies, and vaccines for medical use; amino acids and enzymes for food manufacturing; and biofuels and biochemicals for industrial applications. BTEC provides hands-on education and training in bioprocessing concepts and biomanufacturing methods that comply with cGMP (current Good Manufacturing Practice), a set regulations published by the United States Food and Drug Administration (FDA).

BTEC reports administratively through the university's College of Engineering and is guided by an advisory board made up of representatives from the biomanufacturing industry and other organizations interested in biotechnology and biomanufacturing.

In 2003, North Carolina's Golden LEAF Foundation provided almost $39 million to build BTEC, as part of a larger grant to establish a statewide public-private partnership now called NCBioImpact.[1][2] The state of North Carolina provided funds for process equipment and supports the operation of the facility. The NCBioImpact partnership now includes BTEC, BRITE (Biomanufacturing Research Institute and Technology Enterprise) at North Carolina Central University, North Carolina BioNetwork of the North Carolina Community College System, NCBIO (North Carolina Biosciences Organization), the North Carolina Biotechnology Center, and the Golden LEAF Foundation. It was created to provide workforce training and development for the biotechnology industry, thereby fostering the growth of this economic sector in the state. According to the North Carolina Biotechnology Center, North Carolina is home to 528 biotechnology companies that provide 57,000 jobs and $1.92 billion in taxes for state and local government.[3] Employment in the industry has grown 4.1% from 2008 to 2010, when other industries shed thousands of jobs.[4] In recent years some of the world's largest pharmaceutical companies, e.g. Novartis and Merck, have located and/or expanded manufacturing operations in North Carolina.[5][6]

Photo of exterior of BTEC facility.
BTEC Facility

Facilities and equipment

BTEC opened in fall 2007 and was the first facility dedicated to biomanufacturing training.[7] BTEC is 82,500 gross square feet and contains 63,000-gross square feet of laboratories, which range from small or bench scale to large-scale suites that simulate a biomanufacturing pilot plant capable of producing biopharmaceutical products. Upstream processes utilize bacteria, yeast, animal cells, and insect cells. Equipment in these spaces includes the following:

Photo of BTEC's 30L and 300L bioreactor.
Bioreactors in BTEC's Simulated GMP Lab

The main BTEC facility is home to the North Carolina Community College System's BioNetwork Capstone Center, which operates an aseptic processing/filling suite and several bench-scale labs.[8] In 2012, BTEC completed construction of additional laboratories in a nearby facility for cell culture, purification, and processing of active virus.

University programs

BTEC delivers undergraduate and graduate courses to North Carolina State University students. Academic programs include the following:

Curriculum was created with extensive input from industry professionals, and most courses include substantial hands-on laboratory work. Most BTEC courses are offered in a half-semester (eight-week) format, which enables students to complete a series of courses in one academic year.

Job training

BTEC collaborates with industry partners to design, develop and deliver courses that provide professionals working for biomanufacturing companies, equipment vendors, or regulatory agencies with continuing education opportunities. Open-enrollment courses are offered throughout the year and are available to all interested parties. BTEC also regularly delivers courses customized to meet a client's specific needs for training.

BTEC provides biomanufacturing training specified in contracts of grants to provide training for government agencies. In 2007, the FDA awarded BTEC a 5-year contract to develop and deliver biomanufacturing training for FDA inspectors.[9] In 2010, BTEC received a grant for almost $900,000 from Biomedical Advanced Research and Development Authority (BARDA), part of the United States Department of Health and Human Services.[10] With funding from this grant, a team of instructors from BTEC, Duke University, and industry provide a three-week course on influenza vaccine manufacturing. Trainees were selected by institutions participating in a U.S. government-sponsored program to build vaccine production capacity among countries with developing economies. Countries represented included Egypt, India, Indonesia, Mexico, Romania, Serbia, Russia, South Korea, Thailand, and Vietnam.

Bioprocess and analytical services

When laboratories are not being used for training, BTEC uses them to perform a variety of services for scientists from industry, government, and academia. Projects involve technology development, process improvement/scale-up, analytical testing, and preparation of material for preclinical studies. These services allow scientists to advance their research projects toward commercialization. In turn, these advancements stimulate the North Carolina economy.

Location

BTEC is located on the Centennial Campus of North Carolina State University in Raleigh, North Carolina, United States. The campus is approximately 15 miles east of Research Triangle Park and Raleigh-Durham International Airport.

References

  1. ↑ "2003 Annual Report for the North Carolina Biotechnology Center" (PDF). ncbiotech.org.
  2. ↑ "WRALtechwire article". wraltechwire.com.
  3. ↑ "Cultivating a Rich Biotech Landscape". ncbiotech.org. Retrieved 2011-10-11.
  4. ↑ "Economic Development". ncbioimpact.org. Retrieved 2011-10-11.
  5. ↑ "Novartis Plans to Produce Vaccines by 2011". ncbiotech.org.
  6. ↑ "Merck Expansion Adds to Vaccine Core". ncbiotech.org.
  7. ↑ "2007 Annual Report for the North Carolina Biotechnology Center" (PDF). ncbiotech.org.
  8. ↑ "Capstone Center". ncbionetwork.org.
  9. ↑ "NCBIO Newsletter November 2007". ncbioscience.org.
  10. ↑ "BARDA grants help build global flu vaccine manufacturing capacity". www.businesswire.com.

External links

This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.